Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Supply chain

Drugs companies asked to put no-deal Brexit stockpiles 'on hold' until further notice

The Department of Health and Social Care (DHSC) has written to pharmaceutical companies asking them to keep their six-week stockpiles of medicines “in place but on hold” until further notice.

In a parliamentary statement, health minister Stephen Hammond said the DHSC wrote to companies on 26 April 2019 asking “that all ‘no deal’ Brexit measures, such as stockpiles and additional buffer stocks, should remain in place but on hold until further guidance is available”.

This comes after a statement from the government on 16 April 2019 saying that it would “review its position” on drug stockpiles held in case of a no-deal Brexit after the UK agreed a second extension for the Brexit deadline with the EU.

In August 2018, pharmaceutical companies were asked to develop six-week stockpiles for some drugs to ensure a continuous supply in the event of a no-deal Brexit.

However, following an EU summit on 10 April 2019, an agreement  was put in place with the EU that extended the Article 50 process so that the UK could remain in the EU until 31 October 2019.

Pharmaceutical companies said at the time that they were working with the government to review the guidance in light of the extension.

Following the DHSC’s latest advice, a spokesperson for the Association of the British Pharmaceutical Industry admitted “it is not easy for companies to hold large amounts of stock on a rolling basis”.

“That’s why we’re working with the government to review contingency plans to take the best approach in preparing for a possible ‘no deal’ from the end of October,” they said, adding that stockpiling medicines “has been just one aspect of company contingency planning” for a no-deal Brexit.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206563

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Handbook of Drug Administration via Enteral Feeding Tubes

    Handbook of Drug Administration via Enteral Feeding Tubes

    All you need to know about prescribing or administering drugs via enteral feeding tubes. Over 400 drug monographs as well as facts to inform clinical decision making.

    £54.00Buy now
  • Prescribing Medicines for Children

    Prescribing Medicines for Children

    Prescribing Medicines for Children is designed to improve understanding on all aspects of paediatric prescribing, from the development of suitable drugs through to their practical administration.

    £60.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £43.00Buy now
  • Palliative Care Formulary (PCF6)

    Palliative Care Formulary (PCF6)

    Palliative Care Formulary is a comprehensive combination of independent information about drugs used in palliative care.

    £55.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.